Sandra Horning's Net Worth
$3.15 Million
Who is Sandra Horning?
Sandra Horning has an estimated net worth of $3.15 Million. This is based on reported shares across multiple companies, which include GILEAD SCIENCES, INC., Moderna, Inc., EQRx, Inc., Olema Pharmaceuticals, Inc., Foundation Medicine, Inc., and Revolution Medicines, Inc..
SEC CIK
Sandra Horning's CIK is 0001638709
Past Insider Trading and Trends
2023 was Sandra Horning's most active year for acquiring shares with 11 total transactions. Sandra Horning's most active month to acquire stocks was the month of April. 2023 was Sandra Horning's most active year for disposing of shares, totalling 5 transactions. Sandra Horning's most active month to dispose stocks was the month of October. 2022 saw Sandra Horning paying a total of $972,458.85 for 168,891 shares, this is the most they've acquired in one year. In 2023 Sandra Horning cashed out on 993,359 shares for a total of $0.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
GILEAD SCIENCES, INC. (GILD) Snapshot price: $74.465
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 8
| |||
Form 4
| +108.20% | 1.89K |
—
|
—
| 3.63K |
May 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 5
| |||
Form 4
| +175.95% | 1.11K |
—
|
—
| 1.74K |
May 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 12
| |||
Form 4
|
∞
| 632 |
—
|
—
| 632 |
Jan 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 28
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Moderna, Inc. (MRNA) Snapshot price: $100.17
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 3
| |||
Form 4
| +95.31% | 670 |
—
|
—
| 1.37K |
Apr 28
| |||
Form 4
|
∞
| 703 |
—
|
—
| 703 |
Apr 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 29
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
EQRx, Inc. (EQRX) No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -470.25K |
—
|
—
|
0
|
Nov 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 30
| |||
Form 4
|
∞
| 470.25K |
—
|
—
| 470.25K |
Dec 17
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Olema Pharmaceuticals, Inc. (OLMA) Snapshot price: $15.345
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 16
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Jun 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 18
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Foundation Medicine, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||